Precancerous lesions in the stomach: From biology to clinical patient management

Correa, 1988, A human model of gastric carcinogenesis, Cancer Res, 48, 3554 Correa, 2004, The biological model of gastric carcinogenesis, IARC Sci Publ, 157, 301 Correa, 1992, Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention, Cancer Res, 52, 6735 Morson, 1980, Precancerous conditions and epithelial dysplasia in the stomach, J Clin Pathol, 33, 711, 10.1136/jcp.33.8.711 Capelle, 2010, Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands, Gastroenterology, 138, 487, 10.1053/j.gastro.2009.10.051 Humar, 2009, E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man, Cancer Res, 69, 2050, 10.1158/0008-5472.CAN-08-2457 Barber, 2008, Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer, J Pathol, 216, 295, 10.1002/path.2426 Huntsman, 2001, Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations, N Engl J Med, 344, 1904, 10.1056/NEJM200106213442504 Oberhuber, 2000, Gastric polyps: an update of their pathology and biological significance, Virchows Arch, 437, 581, 10.1007/s004280000330 Dirschmid, 2006, Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?, Virchows Arch, 448, 80, 10.1007/s00428-005-0068-2 Graham, 2008, Long-term proton pump inhibitor use and gastrointestinal cancer, Curr Gastroenterol Rep, 10, 543, 10.1007/s11894-008-0100-1 Borch, 2003, Benign gastric polyps: morphological and functional origin, Dig Dis Sci, 48, 1292, 10.1023/A:1024150924457 Dixon, 1996, Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994, Am J Surg Pathol, 20, 1161, 10.1097/00000478-199610000-00001 Ruiz, 2001, Morphometric assessment of gastric antral atrophy: comparison with visual evaluation, Histopathology, 39, 235, 10.1046/j.1365-2559.2001.01221.x Rugge, 2002, Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading, Aliment Pharmacol Ther, 16, 1249, 10.1046/j.1365-2036.2002.01301.x Price, 1991, The Sydney System: histological division, J Gastroenterol Hepatol, 6, 209, 10.1111/j.1440-1746.1991.tb01468.x El-Zimaity, 2001, Gastric intestinal metaplasia: subtypes and natural history, J Clin Pathol, 54, 679, 10.1136/jcp.54.9.679 Offerhaus, 1999, Observer agreement on the grading of gastric atrophy, Histopathology, 34, 320, 10.1046/j.1365-2559.1999.00635.x Jass, 1981, The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma, Histochem J, 13, 931, 10.1007/BF01002633 Cassaro, 2000, Topographic patterns of intestinal metaplasia and gastric cancer, Am J Gastroenterol, 95, 1431, 10.1111/j.1572-0241.2000.02074.x Leung, 2004, Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication, Gut, 53, 1244, 10.1136/gut.2003.034629 Rugge, 2012, Autoimmune gastritis: histology phenotype and OLGA staging, Aliment Pharmacol Ther, 35, 1460, 10.1111/j.1365-2036.2012.05101.x Grundmann, 1975, Histologic types and possible initial stages in early gastric carcinoma, Beitr Pathol, 154, 256, 10.1016/S0005-8165(75)80034-5 Oehlert, 1975, Gastric mucosal dysplasias: what is their clinical significance?, Dtsch Med Wochenschr, 100, 1950, 10.1055/s-0028-1106484 Jass, 1983, A classification of gastric dysplasia, Histopathology, 7, 181, 10.1111/j.1365-2559.1983.tb02234.x Ming, 1984, Gastric dysplasia. Significance and pathologic criteria, Cancer, 54, 1794, 10.1002/1097-0142(19841101)54:9<1794::AID-CNCR2820540907>3.0.CO;2-W Riddell, 1996, Premalignant and early malignant lesions in the gastrointestinal tract: definitions, terminology, and problems, Am J Gastroenterol, 91, 864 Goldstein, 1997, Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading, Hum Pathol, 28, 127, 10.1016/S0046-8177(97)90095-2 Lewin, 1998, Nomenclature problems of gastrointestinal epithelial neoplasia, Am J Surg Pathol, 22, 1043, 10.1097/00000478-199809000-00001 Riddell, 1998, Problems arising from Eastern and Western classification systems for gastrointestinal dysplasia and carcinoma: are they resolvable?, Histopathology, 33, 197, 10.1046/j.1365-2559.1998.00520.x Lauwers, 1999, Gastric epithelial dysplasia, Gut, 45, 784, 10.1136/gut.45.5.784 Takagi, 1967, Polypoid lesions of the stomach – with special reference to atypical epithelial lesions, Gan No Rinsho, 13, 809 Nagayo, 1971, Histological diagnosis of biopsied gastric mucosae with special reference to that of borderline lesions, Gann Monogr, 11, 245 1995 Fenoglio-Preiser, 2000, Gastric carcinoma, 39 Rugge, 2000, Gastric dysplasia: the Padova international classification, Am J Surg Pathol, 24, 167, 10.1097/00000478-200002000-00001 Fassan, 2012, Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy, Am J Clin Pathol, 137, 727, 10.1309/AJCPEU41HTGXSJDQ Schlemper, 2000, The Vienna classification of gastrointestinal epithelial neoplasia, Gut, 47, 251, 10.1136/gut.47.2.251 Bosman, 2010 Houghton, 2004, Gastric cancer originating from bone marrow-derived cells, Science, 306, 1568, 10.1126/science.1099513 Karam, 2008, Cellular origin of gastric cancer, Ann N Y Acad Sci, 1138, 162, 10.1196/annals.1414.023 El-Rifai, 2002, Molecular biology of gastric cancer, Semin Radiat Oncol, 12, 128, 10.1053/srao.2002.30815 Rugge, 2005, Microsatellite instability and gastric non-invasive neoplasia in a high-risk population in Cesena, Italy, J Clin Pathol, 58, 805, 10.1136/jcp.2004.025676 Jin, 2002, Molecular and cellular phenotypic profiles of gastric noninvasive neoplasia, Lab Invest, 82, 1637, 10.1097/01.LAB.0000041712.58604.CC Homma, 2005, Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias, Virchows Arch, 446, 120, 10.1007/s00428-004-1146-6 Chong, 1994, Microsatellite instability in the progression of gastric carcinoma, Cancer Res, 54, 4595 Seruca, 1995, Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile, Int J Cancer, 64, 32, 10.1002/ijc.2910640108 Isogaki, 1999, Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers, Cancer Detect Prev, 23, 204, 10.1046/j.1525-1500.1999.99020.x Lee, 2002, Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma, Am J Pathol, 161, 611, 10.1016/S0002-9440(10)64216-2 Semba, 1996, Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach, Cancer, 77, 1620, 10.1002/(SICI)1097-0142(19960415)77:8+<1620::AID-CNCR6>3.0.CO;2-H Sakurai, 1995, Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality, Pathol Int, 45, 51, 10.1111/j.1440-1827.1995.tb03379.x Tamura, 1994, Mutations of the APC gene occur during early stages of gastric adenoma development, Cancer Res, 54, 1149 Tohdo, 1993, P53 gene mutations in gastric adenomas, Virchows Arch B Cell Pathol Incl Mol Pathol, 63, 191, 10.1007/BF02899260 Lefebvre, 1996, Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein, Science, 274, 259, 10.1126/science.274.5285.259 Tahara, 1999, Stomach-genetic and epigenetic alterations of preneoplastic and neoplastic lesions, 341 Becker, 1994, E-cadherin gene mutations provide clues to diffuse type gastric carcinomas, Cancer Res, 54, 3845 Higashikawa, 1996, Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues, Int J Cancer, 66, 11, 10.1002/(SICI)1097-0215(19960328)66:1<11::AID-IJC3>3.0.CO;2-1 de Vries, 2008, Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands, Gastroenterology, 134, 945, 10.1053/j.gastro.2008.01.071 Saini, 2008, Utilization of upper endoscopy for surveillance of gastric ulcers in the United States, Am J Gastroenterol, 103, 1920, 10.1111/j.1572-0241.2008.01945.x Dinis-Ribeiro, 2012, Endoscopy, 44, 74, 10.1055/s-0031-1291491 Rokkas, 2007, The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis, Helicobacter, 12, 32, 10.1111/j.1523-5378.2007.00563.x Wang, 2011, Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis, Digestion, 83, 253, 10.1159/000280318 De Vries, 2007, Review article: Helicobacter pylori eradication for the prevention of gastric cancer, Aliment Pharmacol Ther, 26, 25, 10.1111/j.1365-2036.2007.03475.x Correa, 2000, Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy, J Natl Cancer Inst, 92, 1881, 10.1093/jnci/92.23.1881 Satoh, 1998, A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori, Helicobacter, 3, 236 Wang, 2003, Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis, J Natl Cancer Inst, 95, 1784, 10.1093/jnci/djg106 Tian, 2010, Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer, Eur J Cancer Prev, 19, 288, 10.1097/CEJ.0b013e328339648c Zhang, 2009, Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions, World J Gastroenterol, 15, 2731, 10.3748/wjg.15.2731 Hung, 2010, Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication, J Gastroenterol Hepatol, 25, 48, 10.1111/j.1440-1746.2009.05974.x Yang, 2007, Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication, Aliment Pharmacol Ther, 25, 455, 10.1111/j.1365-2036.2006.03224.x Leung, 2006, Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial, Clin Cancer Res, 12, 4766, 10.1158/1078-0432.CCR-06-0693 Yanaoka, 2010, Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion, Int J Cancer, 126, 1467 Plummer, 2007, Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population, J Natl Cancer Inst, 99, 137, 10.1093/jnci/djk017 You, 2006, Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions, J Natl Cancer Inst, 98, 974, 10.1093/jnci/djj264 Kirchner, 2001, Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis, Virchows Arch, 439, 512, 10.1007/s004280100477 Hattori, 1986, Development of adenocarcinomas in the stomach, Cancer, 57, 1528, 10.1002/1097-0142(19860415)57:8<1528::AID-CNCR2820570815>3.0.CO;2-3 Srivastava, 2008, Gastric epithelial dysplasia: the Western perspective, Dig Liver Dis, 40, 641, 10.1016/j.dld.2008.02.039 de Vries, 2007, Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands, Gut, 56, 1665, 10.1136/gut.2007.127167 Rugge, 2007, Secondary prevention of gastric cancer, Gut, 56, 1646, 10.1136/gut.2007.133926 Rugge, 2007, Gastritis staging in clinical practice: the OLGA staging system, Gut, 56, 631, 10.1136/gut.2006.106666 Rugge, 1994, Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia, Gastroenterology, 107, 1288, 10.1016/0016-5085(94)90529-0 Rugge, 2003, The long-term outcome of gastric non-invasive neoplasia, Gut, 52, 1111, 10.1136/gut.52.8.1111 Rugge, 2003, Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions, Gut, 52, 453, 10.1136/gut.52.3.453 Garcia, 1999, Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets, J Pathol, 187, 61, 10.1002/(SICI)1096-9896(199901)187:1<61::AID-PATH247>3.0.CO;2-I McDonald, 2008, Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells, Gastroenterology, 134, 500, 10.1053/j.gastro.2007.11.035 Bai, 2002, Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach, Cancer Lett, 176, 47, 10.1016/S0304-3835(01)00753-4 Rugge, 2004, Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia, Am J Surg Pathol, 28, 834, 10.1097/01.pas.0000126776.65815.48 Fassan, 2011, miRNAs in precancerous lesions of the gastrointestinal tract, World J Gastroenterol, 17, 5231, 10.3748/wjg.v17.i48.5231 Tava, 2006, Type or extension of intestinal metaplasia and immature/atypical “indefinite-for-dysplasia” lesions as predictors of gastric neoplasia, Hum Pathol, 37, 1489, 10.1016/j.humpath.2006.05.012 Raftopoulos, 2012, Gastric intraepithelial neoplasia in a Western population, Eur J Gastroenterol Hepatol, 24, 48, 10.1097/MEG.0b013e32834dc1bb Mera, 2005, Long-term follow-up of patients treated for Helicobacter pylori infection, Gut, 54, 1536, 10.1136/gut.2005.072009 Rugge, 2003, Review article: what have we learnt from gastric biopsy?, Aliment Pharmacol Ther, 17, 68, 10.1046/j.1365-2036.17.s2.15.x Cho, 2011, Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification, Endoscopy, 43, 465, 10.1055/s-0030-1256236 Oshima, 1986, Evaluation of a mass screening program for stomach cancer with a case-control study design, Int J Cancer, 38, 829, 10.1002/ijc.2910380608 Lee, 2006, Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan, Int J Cancer, 118, 2315, 10.1002/ijc.21664 Vaananen, 2003, Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study, Eur J Gastroenterol Hepatol, 15, 885, 10.1097/00042737-200308000-00009 Watabe, 2005, Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study, Gut, 54, 764, 10.1136/gut.2004.055400 de Vries, 2007, The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection, Helicobacter, 12, 1, 10.1111/j.1523-5378.2007.00475.x de Vries, 2009, The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice, Gastrointest Endosc, 70, 18, 10.1016/j.gie.2008.08.041 Rugge, 2005, Staging gastritis: an international proposal, Gastroenterology, 129, 1807, 10.1053/j.gastro.2005.09.056 Rugge, 2008, OLGA staging for gastritis: a tutorial, Dig Liver Dis, 40, 650, 10.1016/j.dld.2008.02.030 Satoh, 2008, Assessment of atrophic gastritis using the OLGA system, Helicobacter, 13, 225, 10.1111/j.1523-5378.2008.00599.x Capelle, 2010, The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis, Gastrointest Endosc, 71, 1150, 10.1016/j.gie.2009.12.029 Malfertheiner, 2012, Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report, Gut, 61, 646, 10.1136/gutjnl-2012-302084 Rugge, 2012, Clinical guidelines: secondary prevention of gastric cancer, Nat Rev Gastroenterol Hepatol, 9, 128, 10.1038/nrgastro.2012.19 You, 1999, Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer, Int J Cancer, 83, 615, 10.1002/(SICI)1097-0215(19991126)83:5<615::AID-IJC8>3.0.CO;2-L Rugge, 1995, Gastric epithelial dysplasia. How clinicopathologic background relates to management, Cancer, 76, 376, 10.1002/1097-0142(19950801)76:3<376::AID-CNCR2820760305>3.0.CO;2-A Kim, 2010, Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions, Endoscopy, 42, 620, 10.1055/s-0030-1255524 Genta, 1999, Gastric precancerous lesions: heading for an international consensus, Gut, 45, I5, 10.1136/gut.45.2008.i5 Genta, 2001, Review article: pre-neoplastic states of the gastric mucosa – a practical approach for the perplexed clinician, Aliment Pharmacol Ther, 15, 43, 10.1046/j.1365-2036.2001.00110.x Weinstein, 1994, Gastric dysplasia and its management, Gastroenterology, 107, 1543, 10.1016/0016-5085(94)90561-4 Bearzi, 1994, Gastric dysplasia: a ten-year follow-up study, Pathol Res Pract, 190, 61, 10.1016/S0344-0338(11)80497-8 Lansdown, 1990, High-grade dysplasia of the gastric mucosa: a marker for gastric carcinoma, Gut, 31, 977, 10.1136/gut.31.9.977 Park, 2008, Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma, Eur J Gastroenterol Hepatol, 20, 966, 10.1097/MEG.0b013e3283013d58 Yamada, 2004, Long-term follow-up study of gastric adenoma/dysplasia, Endoscopy, 36, 390, 10.1055/s-2004-814330